BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12460889)

  • 21. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
    Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG
    Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
    Sato E; Fujimoto J; Tamaya T
    Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer.
    Gong W; Jiang Y; Wang L; Wei D; Yao J; Huang S; Fang S; Xie K
    Clin Cancer Res; 2005 Aug; 11(16):5778-83. PubMed ID: 16115916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic role of angiogenesis in breast cancer.
    Leek RD
    Anticancer Res; 2001; 21(6B):4325-31. PubMed ID: 11908687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of tumor angiogenesis with clinicopathologic prognostic parameters in choroidal melanoma].
    Wang FH; Li B; Sun XL; Li LQ; Chen CX
    Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):68-72. PubMed ID: 12783682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
    Saito T; Hara N; Kitamura Y; Komatsubara S
    Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
    Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
    J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular density of breast cancer in bone metastasis: influence of therapy.
    Lörincz T; Tóth J; Szendröi M; Tímár J
    Anticancer Res; 2005; 25(4):3075-81. PubMed ID: 16080568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
    Shi L; Chen XM; Wang L; Zhang L; Chen Z
    Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
    Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S
    Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
    Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
    J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.